SOLV
Solventum Corporation
NYSE · Healthcare · Medical - Care Facilities · US
$91.69
−0.81%Year over year
Reported trailing growth
- Revenue
- -0.9%
- EBITDA
- +103.6%
- EBIT
- +167.3%
- EPS
- +275.3%
- Free cash flow
- —
- Operating cash flow
- -64.3%
Forward estimates
Based on analyst estimates
- Revenue
- +0.8%
- EBITDA
- -16.0%
- EPS
- -18.0%
Three-year CAGR
- Revenue
- +0.8%
- EBITDA
- +3.9%
- EBIT
- +8.8%
- Net income
- +5.0%
- EPS
- +4.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026